Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis

Satoshi Soen, Hideaki Kishimoto, Hiroshi Hagino, Teruki Sone, Hiroaki Ohishi, Tsukasa Fujimoto, Emma Sasaki, Sakae Tanaka, Toshitsugu Sugimoto
  • Journal of Bone and Mineral Metabolism, August 2019, Springer Science + Business Media
  • DOI: 10.1007/s00774-019-01031-x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr. Sakae Tanaka